LDC Pharma Extension Request At WTO Yields Support But Needs Further Discussion 11/06/2015 by Catherine Saez, Intellectual Property Watch 2 Comments World Trade Organization members this week could not decide on a request from least-developed countries to extend a waiver allowing them to forego the enforcement of intellectual property rights on pharmaceutical products until their economies are stronger. Discussions are expected to be conducted informally until the next meeting of the organisation’s council on IP rights in October.
WTO Director Calls 2015 A ‘Decisive’ Year, Says WIPO GI Act A Boost To WTO IP Talks 11/06/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment World Trade Organization Director General Roberto Azevêdo said at a press event yesterday that 2015 is a decisive year for the organisation. One of the main features is the potential conclusion of the Doha Development Agenda. He also said a recent agreement on geographical indications at the World Intellectual Property Organization would provide a boost to IP talks at WTO.
IP Key For Financing Innovation, Speakers Say At WTO 10/06/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment Intellectual property protection is vital to finance innovation and in particular for start-ups, according to speakers at an event co-organised this week by the European Union, Switzerland, and the United States at the World Trade Organization.
The Chilean Mining Industry: The Role Of IP In The Innovation Process 09/06/2015 by Eimear Murphy for Intellectual Property Watch Leave a Comment The mining industry in Chile offers an interesting case study on the role of intellectual property in the innovation process, according to a discussion at a recent event held at the World Intellectual Property Organization.
Confidential USTR Emails Show Close Industry Involvement In TPP Negotiations 05/06/2015 by William New, Intellectual Property Watch 45 Comments While a full range of stakeholders would be affected by the outcome of the Trans-Pacific Partnership (TPP) agreement under secret negotiation by the United States and a dozen trading partners, corporate representatives have had a special seat at the negotiating table, as shown by hundreds of pages of confidential emails from the US Trade Representative’s office obtained by Intellectual Property Watch. The emails give a rare and fascinating perspective on how policy is developed in the trade office.
IPRs Feature Prominently In WTO Trade Policy Review Of India 03/06/2015 by William New, Intellectual Property Watch 1 Comment Intellectual property rights are among the issues given detailed analysis in the latest trade policy review of India by the World Trade Organization under review this week. Turns out, India has been quite busy on IP rights over the past few years.
European Parliament Trade Committee Tries To Defuse TTIP Controversy But Outcome Remains Uncertain 29/05/2015 by Dugie Standeford for Intellectual Property Watch 1 Comment European Commission negotiators should back away from a controversial provision in the Transatlantic Trade and Investment Partnership (TTIP) deal that would allow companies to sue governments in arbitration courts over claimed unequal treatment, the European Parliament International Trade Committee (INTA) said on 28 May. MEPs called instead for publicly appointed, independent judges, public hearings and an appellate mechanism that respects the jurisdiction of EU and national courts, the committee said.
140+ NGOs Urge WTO Members To Grant Extension Of LDC Pharma Waiver 29/05/2015 by Catherine Saez, Intellectual Property Watch 3 Comments Over 140 non-governmental organisations, most of them local from developing countries, have co-signed a letter to World Trade Organization members to ask they agree to a request by least-developed countries to extend a waiver on their obligation to enforce intellectual property rights on pharmaceutical products.
Panel: Compulsory Licensing Could Address High-Priced Medicines In Europe 28/05/2015 by Eimear Murphy for Intellectual Property Watch 3 Comments The high prices of medicine, which affects access to affordable medicine, was a theme of the annual World Health Assembly over the past week. In one side event, a panel discussed compulsory licensing as a vehicle to be used in combatting the high prices of medicine, not only in developing countries, but in Europe.
An Interview With WIPO Director General Francis Gurry On The New Lisbon Act For GIs 25/05/2015 by Catherine Saez, Intellectual Property Watch 1 Comment Members of the Lisbon Agreement for the Protection of Appellations of Origin and their International Registration on 20 May agreed on a new Act of the agreement, extending protection previously granted only to appellations of origins to geographical indications. The World Intellectual Property Organization is responsible for this agreement. After the signing ceremony at WIPO, Intellectual Property Watch sat down with WIPO Director General Francis Gurry to discuss the new Act.